Surmodics (SRDX) Competitors $28.70 -0.42 (-1.44%) Closing price 04:00 PM EasternExtended Trading$28.70 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SRDX vs. IART, OFIX, ANGO, ARAY, RMTI, ABT, ISRG, BSX, SYK, and MDTShould you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Integra LifeSciences (IART), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry. Surmodics vs. Its Competitors Integra LifeSciences Orthofix Medical AngioDynamics Accuray Rockwell Medical Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Surmodics (NASDAQ:SRDX) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership. Does the media favor SRDX or IART? In the previous week, Integra LifeSciences had 4 more articles in the media than Surmodics. MarketBeat recorded 5 mentions for Integra LifeSciences and 1 mentions for Surmodics. Surmodics' average media sentiment score of 1.02 beat Integra LifeSciences' score of 0.70 indicating that Surmodics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surmodics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, SRDX or IART? Surmodics has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Do analysts prefer SRDX or IART? Surmodics currently has a consensus price target of $43.00, indicating a potential upside of 49.83%. Integra LifeSciences has a consensus price target of $18.43, indicating a potential upside of 27.09%. Given Surmodics' stronger consensus rating and higher probable upside, equities research analysts clearly believe Surmodics is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surmodics 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Integra LifeSciences 5 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.70 Is SRDX or IART more profitable? Surmodics has a net margin of -14.59% compared to Integra LifeSciences' net margin of -30.87%. Integra LifeSciences' return on equity of 12.15% beat Surmodics' return on equity.Company Net Margins Return on Equity Return on Assets Surmodics-14.59% -2.99% -1.99% Integra LifeSciences -30.87%12.15%4.32% Do insiders & institutionals hold more shares of SRDX or IART? 96.6% of Surmodics shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 8.9% of Surmodics shares are held by insiders. Comparatively, 3.5% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, SRDX or IART? Integra LifeSciences has higher revenue and earnings than Surmodics. Surmodics is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurmodics$126.08M3.26-$11.54M-$1.23-23.33Integra LifeSciences$1.61B0.70-$6.94M-$6.53-2.22 SummarySurmodics beats Integra LifeSciences on 9 of the 16 factors compared between the two stocks. Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRDX vs. The Competition Export to ExcelMetricSurmodicsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$416.35M$10.98B$6.16B$10.58BDividend YieldN/A1.83%5.66%4.69%P/E Ratio-23.3314.7265.0423.37Price / Sales3.2628.76612.06135.37Price / Cash94.1225.6126.3031.10Price / Book3.453.4812.876.67Net Income-$11.54M$210.63M$3.30B$276.23M7 Day Performance-4.05%2.52%4.80%3.31%1 Month Performance-11.37%2.31%8.11%10.76%1 Year Performance-25.30%-6.64%75.85%33.58% Surmodics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRDXSurmodics4.5449 of 5 stars$28.70-1.4%$43.00+49.8%-24.2%$416.35M$126.08M-23.33450Positive NewsIARTIntegra LifeSciences4.0037 of 5 stars$13.63+3.3%$18.43+35.2%-12.9%$1.03B$1.61B-2.094,396Positive NewsOFIXOrthofix Medical2.9271 of 5 stars$14.36+0.5%$21.75+51.5%-4.4%$564.37M$799.49M-4.531,616ANGOAngioDynamics4.07 of 5 stars$10.74+0.6%$19.00+76.9%+90.8%$433.97M$292.50M-12.94760Earnings ReportAnalyst ForecastARAYAccuray4.494 of 5 stars$1.63-2.4%$5.00+206.7%-11.5%$188.17M$458.51M-81.501,040Gap UpRMTIRockwell Medical3.3037 of 5 stars$1.27flat$4.00+215.0%-66.5%$43.73M$87.97M-21.17300Positive NewsShort Interest ↑ABTAbbott Laboratories4.9577 of 5 stars$133.01-0.4%$145.22+9.2%+19.4%$232.44B$43.11B16.67114,000Positive NewsISRGIntuitive Surgical4.952 of 5 stars$439.22-0.4%$595.95+35.7%-6.1%$158.13B$8.35B61.2615,638Positive NewsAnalyst UpgradeBSXBoston Scientific4.9269 of 5 stars$96.89-1.3%$118.38+22.2%+15.1%$145.48B$16.75B57.6753,000Analyst DowngradeAnalyst RevisionSYKStryker4.9613 of 5 stars$369.02flat$430.33+16.6%+5.5%$141.08B$22.60B48.8853,000Positive NewsMDTMedtronic4.8316 of 5 stars$94.00-0.2%$102.27+8.8%+10.6%$120.85B$34.20B25.8995,000Positive NewsAnalyst Downgrade Related Companies and Tools Related Companies Integra LifeSciences Competitors Orthofix Medical Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Boston Scientific Competitors Stryker Competitors Medtronic Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRDX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
